YNL134C Antibody

What is the specificity of YNL134C Antibody?

YNL134C Antibody specifically targets the YNL134C protein in Saccharomyces cerevisiae (Baker's yeast), strain ATCC 204508/S288c. The antibody has been generated using recombinant YNL134C protein as the immunogen and purified through antigen affinity methods to ensure specificity. When planning experiments, researchers should consider that the antibody has been validated specifically for this strain, and cross-reactivity with other yeast strains would need to be independently verified .

What are the validated applications for YNL134C Antibody?

The YNL134C Antibody has been tested and validated for two primary applications:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blot (WB)

These applications enable researchers to detect and quantify YNL134C protein in different experimental contexts. The antibody is specifically intended for research purposes only and should not be used for diagnostic or therapeutic procedures .

How should YNL134C Antibody be stored to maintain optimal reactivity?

Proper storage of YNL134C Antibody is crucial for maintaining its activity and specificity. Upon receipt, the antibody should be stored at either -20°C or -80°C. Importantly, researchers should avoid repeated freeze-thaw cycles as this can degrade the antibody and reduce its effectiveness. The antibody is supplied in a storage buffer containing 0.03% Proclin 300 as a preservative and 50% Glycerol, 0.01M PBS at pH 7.4 as constituents, which helps maintain stability during storage .

What controls should be included when using YNL134C Antibody in Western Blot experiments?

When designing Western Blot experiments with YNL134C Antibody, researchers should implement the following controls:

Including these controls helps distinguish between specific signals and experimental artifacts, ensuring reliable and reproducible results .

How can I optimize YNL134C Antibody concentration for different experimental applications?

Optimizing antibody concentration is essential for balancing signal strength and specificity. For YNL134C Antibody, consider the following titration approach:

• Initial Western Blot Optimization:

  • Test a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000)

  • Use consistent sample amounts and identical experimental conditions

  • Select the dilution that provides the best signal-to-noise ratio

• ELISA Optimization:

  • Prepare a broader dilution series (1:100 to 1:10,000)

  • Include both positive and negative controls at each dilution

  • Generate a titration curve to identify the optimal working concentration

• Application-Specific Considerations:

  • Higher concentrations may be needed for less abundant proteins

  • Lower concentrations typically reduce background but may also reduce specific signal

  • Consider extended incubation times at 4°C to enhance signal with lower antibody concentrations

How does sample preparation affect YNL134C detection in yeast lysates?

Sample preparation significantly impacts the detection of YNL134C in yeast cells. Researchers should consider:

• Cell Lysis Methods:

  • Mechanical disruption (glass beads, sonication) preserves most protein structures

  • Enzymatic methods (zymolyase treatment) may be gentler but potentially slower

  • Chemical methods may affect protein epitopes recognized by the antibody

• Buffer Composition:

  • Include protease inhibitors to prevent degradation

  • Add phosphatase inhibitors if studying phosphorylation states

  • Consider detergent types and concentrations based on protein localization

• Denaturation Conditions:

  • Optimize temperature and duration of heat denaturation

  • Consider whether reducing agents may affect epitope recognition

  • Test both denaturing and native conditions if working with structural studies

Systematic optimization of each parameter ensures consistent and reliable detection of YNL134C protein across experiments .

How can I use YNL134C Antibody in immunoprecipitation studies to identify protein interaction partners?

Immunoprecipitation (IP) with YNL134C Antibody provides valuable insights into protein-protein interactions. For optimal results:

• Protocol Optimization:

  • Test different lysis buffers with varying detergent strengths

  • Optimize antibody-to-lysate ratios (typically 2-5 μg antibody per mg of protein)

  • Compare direct IP vs. pre-clearing with Protein A/G beads

• Interaction Verification Strategy:

  • Perform reciprocal IP with antibodies against suspected interaction partners

  • Use crosslinking reagents for transient interactions

  • Include isotype control IPs to identify non-specific binding

• Advanced Analysis:

  • Combine with mass spectrometry for unbiased partner identification

  • Use quantitative proteomics to determine interaction stoichiometry

  • Consider proximity labeling techniques (BioID, APEX) as complementary approaches

This methodology can reveal novel insights into YNL134C protein function within cellular pathways and protein complexes .

How can machine learning approaches enhance antibody-antigen binding prediction for YNL134C studies?

Machine learning can significantly improve experimental design and interpretation when working with YNL134C Antibody:

• Epitope Prediction:

  • Computational algorithms can predict likely epitopes on YNL134C protein

  • These predictions help understand potential cross-reactivity with similar proteins

  • Models can be trained on existing antibody-antigen interaction datasets

• Active Learning Implementation:

  • Start with limited experimental data points

  • Use machine learning models to predict optimal next experiments

  • Iteratively refine predictions with new experimental results

• Experimental Efficiency:

  • According to recent research, active learning strategies can reduce the number of required antigen variants by up to 35%

  • This approach can accelerate the experimental timeline by approximately 28 steps compared to random testing

  • Such efficiency is particularly valuable when characterizing new antibodies against yeast proteins

How should I approach epitope mapping for YNL134C Antibody to better understand its binding characteristics?

Understanding the specific epitopes recognized by YNL134C Antibody provides critical insights for experimental design and interpretation:

• Peptide Array Approach:

  • Create overlapping peptide arrays spanning the entire YNL134C sequence

  • Incubate arrays with the antibody to identify binding regions

  • Confirm with competitive binding assays using identified peptides

• Mutagenesis Strategy:

  • Generate point mutations or deletions in recombinant YNL134C

  • Test antibody binding to mutated proteins

  • Map critical residues required for recognition

• Structural Analysis:

  • Use protein structure prediction to identify surface-exposed regions

  • Correlate epitope mapping results with structural models

  • Consider how post-translational modifications might affect epitope accessibility

This comprehensive approach reveals which regions of YNL134C are recognized by the antibody, informing experimental design and potential limitations .

How can I distinguish between true signals and cross-reactivity when working with YNL134C Antibody?

Differentiating specific signals from cross-reactivity requires systematic analysis:

• Validation Approaches:

  • Compare wild-type and YNL134C knockout strains

  • Perform peptide competition assays

  • Analyze multiple antibody lots for consistent binding patterns

• Cross-Reactivity Assessment:

  • Examine band patterns in Western blots (single vs. multiple bands)

  • Compare observed molecular weight with predicted weight

  • Consider sequence similarity between YNL134C and other yeast proteins

• Advanced Validation Techniques:

  • Use mass spectrometry to identify proteins in immunoprecipitates

  • Perform immunodepletion studies

  • Consider orthogonal detection methods (e.g., mass spectrometry, CRISPR screens)

These approaches enable confident interpretation of experimental results by establishing signal specificity .

What factors might contribute to inconsistent results with YNL134C Antibody across experiments?

Several factors can lead to variability in results when working with YNL134C Antibody:

• Antibody-Related Factors:

  • Lot-to-lot variations in polyclonal antibody preparations

  • Antibody degradation due to improper storage or excessive freeze-thaw cycles

  • Potential changes in affinity under different experimental conditions

• Experimental Variables:

  • Variations in sample preparation protocols

  • Inconsistent transfer efficiency in Western blots

  • Differences in blocking efficiency or detection methods

• Biological Variables:

  • Changes in YNL134C expression under different growth conditions

  • Post-translational modifications affecting epitope accessibility

  • Protein complex formation masking antibody binding sites

To address these issues, researchers should standardize protocols, include appropriate controls in each experiment, and consider quantitative normalization methods to account for technical variations .

How should I interpret unexpected molecular weight observations when detecting YNL134C with this antibody?

Unexpected molecular weight observations require careful analysis:

• Common Causes for Molecular Weight Discrepancies:

  • Post-translational modifications (phosphorylation, glycosylation, etc.)

  • Protein cleavage or processing

  • Alternative splicing or translation start sites

  • Incomplete denaturation leading to unusual migration patterns

• Analytical Approach:

  • Compare observed weight with predicted molecular weight

  • Test different sample preparation methods (varying detergents, reducing agents)

  • Consider treating samples with enzymes that remove specific modifications

• Verification Methods:

  • Use mass spectrometry to determine actual protein mass

  • Compare with alternative YNL134C antibodies recognizing different epitopes

  • Analyze YNL134C with specific tags (if available) for verification

This methodical approach helps distinguish between technical artifacts and biologically meaningful observations regarding YNL134C protein characteristics .

How can YNL134C Antibody be adapted for use in immunofluorescence microscopy to study protein localization?

While not explicitly validated for immunofluorescence, researchers can adapt YNL134C Antibody for localization studies:

• Protocol Optimization:

  • Test different fixation methods (formaldehyde, methanol)

  • Optimize permeabilization conditions for yeast cell wall

  • Determine optimal antibody concentration (typically higher than for Western blot)

• Specificity Controls:

  • Compare wild-type with YNL134C deletion strains

  • Use fluorescently tagged YNL134C constructs as co-localization controls

  • Perform peptide competition controls

• Advanced Applications:

  • Consider super-resolution microscopy for detailed localization

  • Combine with markers for specific cellular compartments

  • Use time-lapse imaging with fixation at different timepoints to study dynamic localization

These approaches enable visualization of YNL134C protein distribution within yeast cells, providing insights into its functional roles .

How does the polyclonal nature of YNL134C Antibody impact experimental design and data interpretation?

The polyclonal nature of YNL134C Antibody has important implications:

• Experimental Considerations:

  • Polyclonal antibodies recognize multiple epitopes, potentially increasing sensitivity

  • Batch-to-batch variation may require revalidation with new lots

  • Greater tolerance to minor sample preparation variations compared to monoclonal antibodies

• Data Interpretation Framework:

  • Consider epitope accessibility in different experimental contexts

  • Evaluate whether signals from different epitopes might vary under certain conditions

  • Assess how polyclonal recognition might affect detection of protein variants or modifications

• Experimental Advantages and Limitations:

  • Advantage: Robust detection across different experimental conditions

  • Advantage: Potentially higher signal due to multiple epitope binding

  • Limitation: Possible increased cross-reactivity compared to monoclonal antibodies

  • Limitation: Less consistent lot-to-lot performance requires validation

Understanding these characteristics enables appropriate experimental design and accurate interpretation of results .

How can I integrate YNL134C Antibody into multi-omics approaches to study yeast protein function?

Integrating YNL134C Antibody into multi-omics research requires careful experimental design:

• Proteomics Integration:

  • Use immunoprecipitation followed by mass spectrometry (IP-MS)

  • Compare protein interaction networks under different conditions

  • Correlate antibody-based quantification with global proteomics data

• Transcriptomics Correlation:

  • Compare YNL134C protein levels (detected by antibody) with mRNA expression

  • Investigate post-transcriptional regulation mechanisms

  • Study protein-RNA interactions if YNL134C has RNA-binding capabilities

• Functional Genomics Approaches:

  • Combine with CRISPR/genetic screens to identify functional relationships

  • Correlate phenotypic data with YNL134C protein levels

  • Use antibody to validate hits from genetic screens

This integrated approach provides a comprehensive understanding of YNL134C function within the broader cellular context .